Delivery Order SPE2DR25D3201-SPE2DR26FT6DR
- Not listed
- The Defense Logistics Agency awarded a $1,854.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mitomycin 20 mg vials, with an ultimate completion date of December 17, 2025. This is an unset-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as a primary...
- This delivery order awards $3,179.27 to AmerisourceBergen Drug Corp for the supply of Mitomycin 5 mg vials. The contract is a firm fixed-price award issued by the Defense Logistics Agency (DLA) under a non-competitive set-aside and carries an ultimate completion date of January 29, 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location in Conshohocken, PA. Mitomycin is a chemotherapy agent used...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.58 Firm Fixed Price delivery order is for the supply of 4,568,142,696 units of Mitomycin 5 mg vials, with a performance period through May 6, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,956,675 units of the pharmaceutical product Mitomycin 20 mg vials. The $1,100.72 contract has a performance period through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $7.2K to AmerisourceBergen Drug Corp for the supply of Mitomycin 40 mg vials. This firm fixed-price contract, which was competitively awarded without a set-aside designation, is scheduled for completion by December 19, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under a larger contract vehicle supporting federal pharmaceutical procurement...
- This federal contract award is for the delivery of 5 mg vials of the medication Mitomycin to the Defense Logistics Agency, a defense agency. The $2,292.80 firm fixed price delivery order contract has a completion date of May 16, 2025 and was awarded on May 15, 2025 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $27,081.44 for Mylotarg 4.5 mg vials under a Defense Logistics Agency contract with the Medical Supply Chain. The award, made on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed price, competitively awarded delivery against an existing contract vehicle. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order does not...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,269.84 to AmerisourceBergen Drug Corp for the supply of Mylotarg 4.5 mg vials. This firm fixed-price, competitive delivery order was issued on November 13, 2025, with an ultimate completion date of December 5, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects the vendor's demonstrated capability to meet...
- The Defense Logistics Agency awarded a $2,550.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dactinomycin 500 microgram vials, with an ultimate completion date of September 18, 2025. This non-set-aside delivery order represents a competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran...
- The Defense Logistics Agency awarded a $2,896.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials, with an ultimate completion date of September 12, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026....
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT6DRDelivery Order
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $2,899.00 for the supply of Mitomycin 5 mg vials, with an ultimate completion date of February 2, 2026. This is a firm fixed-price, non-set-aside contract with performance to be executed in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through open competition, with its contract portfolio encompassing specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Mitomycin—a chemotherapy agent—supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems in fulfilling their medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/29/26 |